Synthesis and investigation of magnetite-gold hybrid nanoparticles for visualization and targeted delivery purposes
Mariia Efremova
National University of Science and Technology «MISiS»
Mariia V. Efremova presents the results of work, obtained in «Biomedical Nanomaterials» laboratory, which is a collaboration of NUST «MISiS» and Lomonosov Moscow State University. She is a 3rd-year PhD student. Mariia has had several internships abroad (USA, Japan, Germany) and currently participates in a joint research with the group of M. Farle (University of Duisburg-Essen, Duisburg, Germany). Mariia has several publications in international journals (Angewandte Chemie International Edition, Colloids and Surfaces B: Biointerfaces, Materials Letters). The area of scientific interest: magnetic nanoparticles, magnetite-gold hybrid structures, targeted drug delivery systems, magnetic resonance imaging, chemical enzymology, distant regulation of biomolecules activity.
Abstract
During last decades magnetite and gold nanoparticles (NPs) attract a deep interest of scientists due to their potential application in therapy and diagnostics. Fe3O4 NPs have the ability to enhance T2-contrast in magnetic... [ view full abstract ]
During last decades magnetite and gold nanoparticles (NPs) attract a deep interest of scientists due to their potential application in therapy and diagnostics. Fe3O4 NPs have the ability to enhance T2-contrast in magnetic resonance imaging (MRI) and deliver drugs using an external magnetic field. Au NPs are characterized by high stability, biocompatibility, and can be covalently functionalized by a wide spectrum of thiol-containing ligands. The idea of Fe3O4-Au hybrid material creation is the combination of magnetite and gold promising properties as well as the presence of two types of surfaces.
Hybrid magnetite-gold NPs were obtained by the decomposition of iron pentacarbonyl on the surface of gold NPs. As a result, so-called dumbbell-like structures were obtained where magnetite with spherical (sample D-1, 13±2 nm) or cubic (sample D-2, 23±2 nm) shape and spherical gold NPs were connected together pairwise.
The samples were transferred into water by means of block-copolymer Pluronic F127. R2-relaxivity rates at the level of 167 and 385 mM-1s-1 were obtained for samples D-1 and D-2, respectively; the latter value is a record value for hybrid Fe3O4-Au NPs, exceeding the similar characteristics of commercial contrast agents twice.
The sample D-1 was also used for the selective functionalization of Fe3O4 NPs surface with anti-cancer drug doxorubicin and Au NPs surface – with the ligand of prostate specific membrane antigen (PSMA). Obtained NPs were found to have dose-related toxicity for human prostate cancer cells (LNCaP cell line) and got into the intracellular space after 45 minutes of incubation (according to fluorescence microscopy data). This can be explained by the affinity of the LNCaP cells to the PSMA ligand.
Thereby, in this work magnetite-gold hybrid NPs, which have a strong potential for biomedical application, particularly in targeted drug delivery to liver and prostate cells, and magnetic resonance imaging, were synthesized and characterized. That paves the way to the development of a new theranostic approach.
The authors gratefully acknowledge the financial support of the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST «MISiS» (№K2-2016-069).
Authors
-
Mariia Efremova
(National University of Science and Technology «MISiS»)
-
Yulia Nalench
(National University of Science and Technology «MISiS»)
-
Victor Naumenko
(National University of Science and Technology «MISiS»)
-
Anastasia Garanina
(National University of Science and Technology «MISiS»)
-
Alexandra Prelovskaya
(National University of Science and Technology «MISiS»)
-
Maxim Abakumov
(Pirogov Russian National Research Medical University)
-
Irina Saltykova
(Lomonosov Moscow State University)
-
Alexander Savchenko
(National University of Science and Technology «MISiS»)
-
Natalia Klyachko
(Lomonosov Moscow State University)
-
Alexander Majouga
(Lomonosov Moscow State University)
Topic Areas
Targeted drug delivery and nanocarriers , Nanomedicine for cancer diagnosis & therapy , Nano-Imaging for diagnosis, therapy and delivery
Session
OS1a-A » Multi-Topic (15:00 - Monday, 25th September, Auditorium)
Presentation Files
The presenter has not uploaded any presentation files.